Home/Filings/4/0001193125-25-241643
4//SEC Filing

Jones Bryan 4

Accession 0001193125-25-241643

CIK 0001774857other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 6:12 PM ET

Size

6.9 KB

Accession

0001193125-25-241643

Insider Transaction Report

Form 4
Period: 2025-10-15
Jones Bryan
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-10-15$4.24/sh+1,250$5,3001,250 total
  • Exercise/Conversion

    Stock option (right to buy)

    2025-10-151,25040,052 total
    Exercise: $4.24Exp: 2034-07-20Common Stock (1,250 underlying)
Footnotes (1)
  • [F1]1/48th of the original number of shares subject to the option vested on July 27, 2024, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.

Documents

1 file

Issuer

Aardvark Therapeutics, Inc.

CIK 0001774857

Entity typeother

Related Parties

1
  • filerCIK 0002045615

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 6:12 PM ET
Size
6.9 KB